AzTrials
AzTrials

Alcohol Use Disorder (AUD)NCT04639895

Cognitive Rehabilitation Through Personalized Virtual Reality and Paper-and-pencil Interventions in the Alcohol Use Disorder Treatment.

A study testing Virtual Reality and Paper and Pencil in people with Alcohol Use Disorder (AUD), run by Universidade da Madeira at 1 site in Portugal.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Cognitive dysfunction is one of the different consequences of excessive alcohol consumption, affecting many domains associated with prefrontal and temporal lobes, such as attention, verbal fluency, and memory. Read more about this study

Who is it for?
Ages 35 to 65 years
Conditions the study is for
Alcohol Use Disorder (AUD)
What is being tested?
Virtual Reality and Paper and Pencil
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 sitePortugal
Study dates
22 Oct 2018to 30 Aug 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 35 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Inpatients of Centro de Alcoologia Ricardo Pampuri (with Alcohol use Disorder diagnosis)
  • Education (able to read and write)
  • Standard neuropharmacological protocol

Who cannot join

  • Abuse of other substances
  • Neurological and psychiatric pathology (present or past)
  • Severe depressive symptoms as assessed by the Beck Depression Inventory
  • Visual problems that can affect the performance of the tasks (hemianopsy, diplopia)

Trial locations and contacts

1 site in 1 country.

Portugal1 site
  • Instituto São João de Deus- CSSJD Funchal

    Funchal, 9020-126

Other trials in Portugal

About this study

Official title: Use of Personalized Virtual Reality and Paper-and-pencil Interventions as Complementary Tools in the Treatment of Alcohol Use Disorder: From Cognitive Rehabilitation to the Prevention of Relapses.

Cognitive dysfunction is one of the different consequences of excessive alcohol consumption, affecting many domains associated with prefrontal and temporal lobes, such as attention, verbal fluency, and memory.

This study will explore the clinical impact of two cognitive rehabilitation tools to promote cognitive improvements of AUD individuals.

Read the detailed description

Excessive consumption of alcohol affects many functions associated with the prefrontal and temporal lobes, including different executive functions, memory, and complex motor control. Among several treatments, the Transtheoretical Model, a multidisciplinary approach, is one of the most standardized. However, it lacks effective and innovative cognitive rehabilitation tools. In this study, two cognitive rehabilitation tools, already clinically validated for stroke patients, will be implemented to promote cognitive recovery of Alcohol Use Disorder (AUD) individuals under treatment in the Alcoholic Rehabilitation Center S. Ricardo Pampuri from Casa de Saúde S. João de Deus (Madeira, Portugal). Within a randomized controlled trial with 60 participants, this study intend to assess and compare the clinical effectiveness of both a paper-and-pencil tasks training and content equivalent virtual reality (VR) simulation of activities of daily living with time-matched standard treatment.

Being tested
Virtual Reality, Paper and Pencil, Control Group
Keywords
Alcohol Use Disorder, Cognitive Rehabilitation, Virtual Reality, Paper-and-Pencil Tasks
Medical subject headings
Alcoholism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual RealityProcedure or surgery

    The Virtual Reality group will be involved in the Standard treatment protocol and will perform personalized activities of daily living in a virtual city environment (Reh@City).

  • Paper and PencilProcedure or surgery

    The paper and Pencil group will be involved in the Standard treatment protocol and will perform personalized cognitive paper-and-pencil tasks, using the Task Generator tool.

  • Control GroupProcedure or surgery

    The standard treatment protocol.

Study groups in NCT04639895
Study groupRoleWhat they receive
Virtual RealityExperimentalStandard treatment protocol and 12 sessions (30 minutes each) of personalized cognitive activities in a virtual city environment (Reh@City).
Receives: Procedure: Virtual Reality
Paper and PencilExperimentalStandard treatment protocol and 12 sessions (30 minutes each) of personalized paper-and-pencil cognitive activities,using the Task Generator tool.
Receives: Procedure: Paper and Pencil
Control GroupActive comparatorThe standard treatment protocol.
Receives: Procedure: Control Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Montreal Cognitive Assessment (Cognitive Screening).

    Change from baseline in the Montreal Cognitive Assessment

    Measured: Baseline, Post-intervention (4 weeks), 6-month and 12-month follow-up

  2. Frontal Assessment Battery (FAB- Executive functioning).

    Change from baseline in the Frontal Assessment Battery.

    Measured: Baseline, Post-intervention (4 weeks), 6-month and 12-month follow-up

  3. SF-36 Medical Outcomes Study 36 - Item Short - Form Health Survey

    Change from baseline in the SF-36

    Measured: Baseline, Post-intervention (4 weeks), 6-month and 12-month follow-up

Secondary outcomes (5)
  1. Toulouse-Pieron (Attention).

    Change from baseline in the Toulouse-Pieron Cancellation Test.

    Measured: Baseline, Post-intervention (4 weeks), 6-month and 12-month follow-up

  2. Verbal Paired Associates (WMS-III) (Memory).

    Change from baseline in the Verbal Paired Associates (WMS-III)

    Measured: Baseline, Post-intervention (4 weeks), 6-month and 12-month follow-up

  3. Rey Complex Figure (Visuospatial skills and visual memory).

    Change from baseline in the Rey Complex Figure.

    Measured: Baseline, Post-intervention (4 weeks), 6-month and 12-month follow-up

  4. Symbol Search and Coding (WAIS III).

    Change from baseline in the Symbol Search and Coding (WAIS III)

    Measured: Baseline, Post-intervention (4 weeks), 6-month and 12-month follow-up]

  5. Letter-number sequencing (WAIS-III)- Working Memory

    Change from baseline in the Letter-number sequencing (WAIS III)

    Measured: Baseline, Post-intervention (4 weeks), 6-month and 12-month follow-up]

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Nov 2020
  2. Study start22 Oct 2018
  3. Primary completion30 Aug 2020
  4. Study completion30 Aug 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04639895
Sponsor's protocol ID
1/20
Status last verified
May 2022
First submitted
27 Oct 2020
Last updated
18 May 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality and Paper and Pencil in people with Alcohol Use Disorder (AUD), run by Universidade da Madeira at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 May 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Montreal Cognitive Assessment (Cognitive Screening). (time frame: Baseline, Post-intervention (4 weeks), 6-month and 12-month follow-up). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 May 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in